Multicenter Selective Lymphadenectomy Trial (MSLT)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,001

Participants

Timeline

Start Date

November 30, 1993

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Melanoma
Interventions
PROCEDURE

Sentinel Lymph Node Dissection

Subject has wide excision and sentinel lymph node dissection for primary melanoma.

PROCEDURE

Complete Lymph Node Dissection

Subject has wide excision, sentinel lymph node dissection, and complete lymph node dissection (if positive sentinel node found) for primary melanoma.

PROCEDURE

Wide Excision

Subject has wide excision only for primary melanoma.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Saint John's Cancer Institute

OTHER

NCT00275496 - Multicenter Selective Lymphadenectomy Trial (MSLT) | Biotech Hunter | Biotech Hunter